Clinical trials
Terminated Phase 1/2 trials in New Zealand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 4 |
| Arrowhead Pharmaceuticals | 2 |
| Apollomics (Australia) Pty. Ltd. | 1 |
| Arrow Therapeutics | 1 |
| BeiGene | 1 |
| Dynavax Technologies Corporation | 1 |
| Genmab | 1 |
| Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA | 1 |
| Korro Bio, Inc. | 1 |
| OcuNexus Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Multiple Myeloma | 2 |
| Recurrence | 2 |
| Arthritis, Rheumatoid | 1 |
| Asthma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
| Celiac Disease | 1 |
| Cystic Fibrosis | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.